[HTML][HTML] NRF2 regulation processes as a source of potential drug targets against neurodegenerative diseases
Á Cores, M Piquero, M Villacampa, R León… - Biomolecules, 2020 - mdpi.com
NRF2 acts by controlling gene expression, being the master regulator of the Phase II
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
[PDF][PDF] NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Á Cores, M Piquero, M Villacampa, R León… - docta.ucm.es
NRF2 acts by controlling gene expression, being the master regulator of the Phase II
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Á Cores, M Piquero, M Villacampa, R León… - …, 2020 - pubmed.ncbi.nlm.nih.gov
NRF2 acts by controlling gene expression, being the master regulator of the Phase II
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Á Cores, M Piquero, M Villacampa, R León… - 2020 - agris.fao.org
NRF2 acts by controlling gene expression, being the master regulator of the Phase II
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
[引用][C] NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Á Cores, M Piquero, M Villacampa… - … Processes as a …, 2020 - produccioncientifica.ucm.es
NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases.
Á Cores, M Piquero, M Villacampa… - Biomolecules …, 2020 - search.ebscohost.com
NRF2 acts by controlling gene expression, being the master regulator of the Phase II
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases.
Á Cores, M Piquero, M Villacampa, R León… - Biomolecules, 2020 - europepmc.org
NRF2 acts by controlling gene expression, being the master regulator of the Phase II
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
[HTML][HTML] NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Á Cores, M Piquero, M Villacampa, R León… - …, 2020 - ncbi.nlm.nih.gov
NRF2 acts by controlling gene expression, being the master regulator of the Phase II
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
[PDF][PDF] NRF2 Regulation Processes as a Source of Potential Drug Targets against Neurodegenerative Diseases
Á Cores, M Piquero, M Villacampa, R León… - pdfs.semanticscholar.org
NRF2 acts by controlling gene expression, being the master regulator of the Phase II
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …
antioxidant response, and also being key to the control of neuroinflammation. NRF2 activity …